Spironolactone and Abiraterone Interaction

Drug interaction information between Spironolactone and Abiraterone.

Spironolactone and Abiraterone have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Spironolactone and Abiraterone. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Spironolactone

Anti-Androgen

Drug B

Abiraterone

CYP17 Inhibitor

How They Interact

Spironolactone can interfere with the way abiraterone works against prostate cancer and may cause certain lab tests to show higher cancer markers. This makes it difficult for your doctor to track your progress.

FDA Label Information

• Abiraterone: May increase prostate-specific antigen (PSA) levels ( 7.7 ). 7.7 Abiraterone Spironolactone binds to the androgen receptor and may increase prostate-specific antigen (PSA) levels in abiraterone-treated prostate cancer patients. Concomitant use of spironolactone and abiraterone is not recommended.

Spironolactone Also Interacts With

View all Spironolactone interactions →

Frequently Asked Questions

What SPL severity band is on file for Spironolactone (Acne) + Abiraterone?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

How many labeled pairs sit in each drug's moderate band?

Spironolactone and Abiraterone tie at 7 labeled pairs each. moderate-band counts: Spironolactone 4 alongside Lithium, Trimethoprim, Heparin; Abiraterone 2 alongside Thioridazine.

What mechanism field is on file for Spironolactone (Acne) and Abiraterone?

Spironolactone can interfere with the way abiraterone works against prostate cancer and may cause certain lab tests to show higher cancer markers. This makes it difficult for your doctor to track your progress.

Spironolactone and Abiraterone · moderate-band peers

SPL source-record counts only. This page's band is moderate · classes on file: Spironolactone (Anti-Androgen); Abiraterone (CYP17 Inhibitor).

Spironolactone

0 major · 4 moderate · 3 minor · 7 total

Abiraterone

0 major · 2 moderate · 5 minor · 7 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.